Aging is a multifactorial process which has long been seen as undruggable.
We will discuss various approaches emerging to reverse the trajectory of aging, and what we can do to enhance our time in a state of independence.
- Leading scientific themes of aging research, such as senescence, epigenetics, metabolism, exercise and inflammation
- Diseases of aging and clinical strategy
- Lifestyle changes we can undertake to enhance healthy aging
VIKTORIA KHEIFETS, PHD
Sr. Vice President Research
Viktoria Kheifets is Senior Vice president at Alkahest where she leads a cross functional team to identify plasma bioactives and their mechanisms of reversing age-dependent decline in the brain and other critical organ systems. Prior to Alkahest, Viktoria focused on new company formation at Third Rock Ventures in the fields of liver regeneration and immunometabolism. She was a Senior Group Leader of Biology at Edison Pharmaceutics where she headed drug discovery efforts in orphan mitochondrial diseases and diseases of aging. Viktoria obtained her scientific training at MIT and Stanford.
MARCO QUARTA, PHD
Rubedo Life Sciences
Co-Founder and CEO
Marco Quarta, PhD, CEO received his doctorate degree in Biotechnology from the University of Bologna and a Ph.D. in Neuroscience from the University of Padua. He completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University. He continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital in Palo Alto, CA. While there, he established a translational program in regenerative medicine. He has over 35 publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation.
Marco also co-founded and led Turn Biotechnology, Wetware Concepts and YEBN and served as an executive board member of the European Federation of Biotechnologies. He currently sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) Calpoly Bridge program, and the advisory board at the Center for Healthcare Innovation. Marco is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University, one of the most prestigious institutions supporting the science of aging.
VP, Business Development
Julie Klerman has bridged her passion for medicine, science, and travel by specializing in turning innovative health tech solutions into successful commercial products.
She has 12+ years of experience leading innovation and strategy initiatives, including expertise in strategic planning, insight and ideation, financial modeling, opportunity sizing, and business development. Julie has entrepreneurial spirit and a restless heart with a proven track record of building partner relationships, growing revenue, and creating change in a commercial environment.
Light Dinner and refreshments provided.